Kyle Jenne sold $2.8M of Ionis Pharmaceuticals (IONS)

Executed Mar 10, disclosed Mar 11, 1 day later.

Value, as filed

$2.8M

37,277 sh across 2 lots

Executed

Mar 10

the trade date, as filed

Disclosed

Mar 11

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

KJ Kyle Jenne EVP, Chf GL Pdt Str Ofcr profile →

Kyle Jenne (EVP, Chf GL Pdt Str Ofcr) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Ionis Pharmaceuticals, Inc. (IONS). The largest single filing was $2.8M of IONS (37,277 sh across 2 lots, as filed), executed Mar 10.

The name

IONS Ionis Pharmaceuticals, Inc. IONS · Healthcare · 119 filings in 24 months ticker →

Healthcare · Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Kyle Jenne in IONS

IONSSALE Ionis Pharmaceuticals, Inc. $368K
4,902 sh × $75.17
Exec Apr 16
Filed Apr 17 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $138K
1,823 sh × $75.96
Exec Jan 16
Filed Jan 20 · 5:30 PM ET